These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5676798)

  • 1. The effect of disease, drugs, and dilution on the binding of sulfonamides in human plasma.
    Anton AH
    Clin Pharmacol Ther; 1968; 9(5):561-7. PubMed ID: 5676798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Binding of some sulfanilamides to blood proteins of man. 1. Determinations of low sulfanilamide concentrations in vitro at room temperature].
    Spring P
    Arzneimittelforschung; 1966 Mar; 16(3):346-54. PubMed ID: 6013844
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations.
    Tuomisto J; Saris NE
    Ann Med Exp Biol Fenn; 1970; 48(1):38-48. PubMed ID: 5419724
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of simultaneous administration of drugs on absorption and excretion. XV. Effect of probenecid on plasma protein binding of sulfadimethoxine in rabbits: the role of N4-acetylsulfadimethoxine, the major metabolite of sulfadimethoxine.
    Imamura Y; Mori H; Ichibagase H
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):274-8. PubMed ID: 6850942
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of simultaneous administration of drugs on absorption and excretion. XVI. Effect of probenecid on plasma protein binding of sulfadimethoxine in fast and slow acetylator rabbits.
    Imamura Y; Mori H; Ichibagase H
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1768-71. PubMed ID: 6616727
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.
    Berneis K; Boguth W
    Chemotherapy; 1976; 22(6):390-409. PubMed ID: 954483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of probenecid on plasma concentration and tissue distribution of sulfadimethoxine in fast and slow acetylator rabbits].
    Imamura Y; Mori H; Otagiri M
    Yakugaku Zasshi; 1988 Apr; 108(4):345-9. PubMed ID: 3216329
    [No Abstract]   [Full Text] [Related]  

  • 9. [METABOLIC FATE OF DELAYED-ACTION SULFONAMIDES].
    SALVI G; PLANCHER AC
    Farmaco Prat; 1964 Feb; 19():75-83. PubMed ID: 14138309
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANTIBACTERIAL SULFONAMIDES].
    TREFOUEL J
    Prod Probl Pharm; 1964 Jan; 19():3-14. PubMed ID: 14135919
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 12. Disc-agar diffusion microbiological assay procedure for determining serum and urine levels of sulfacytine and other sulfonamides.
    Heifetz CL; Chodubski JA; DeCarlo MO; Fisher MW
    Appl Microbiol; 1971 May; 21(5):893-8. PubMed ID: 4930038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluative bases for new sulfonamides].
    WALTER AM
    Chemotherapia (Basel); 1963; 6():161-79. PubMed ID: 13998665
    [No Abstract]   [Full Text] [Related]  

  • 14. [CERTAIN MICROBIOLOGICAL PECULIARITIES OF NEW SULFANILAMIDES].
    KUTZSCHE A
    Chemotherapia (Basel); 1964; 64():53-62. PubMed ID: 14178045
    [No Abstract]   [Full Text] [Related]  

  • 15. [SULFONAMIDES].
    BOERGER HH
    Ther Ggw; 1963 Sep; 102():1037-44. PubMed ID: 14057434
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the protein-binding of long-acting sulfonamides].
    SCHOLTAN W
    Chemotherapia (Basel); 1963; 6():180-95. PubMed ID: 13992327
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of antimicrobial agents on bilirubin binding by human erythrocytes.
    Bratlid D
    Scand J Clin Lab Invest; 1972 Nov; 30(3):331-7. PubMed ID: 4629675
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the distribution of long-acting sulfanilamides in purulent pyelonephritis in rats].
    Rudzit EA; Ostapchuk NV; Bobrov VI
    Antibiotiki; 1983 Nov; 28(11):837-41. PubMed ID: 6651273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MANAGEMENT ACUTE PYELONEPHRITIS.
    SMYTHE CM
    Mod Treat; 1964 Jan; 1():63-77. PubMed ID: 14161717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.